1. Baicalein, unlike 4-hydroxytamoxifen but similar to G15, suppresses 17β-estradiol-induced cell invasion, and matrix metalloproteinase-9 expression and activation in MCF-7 human breast cancer cells
    Yan Chen et al, 2017, Oncology Letters CrossRef
  2. Unraveling the Role of Scutellaria baicalensis for the Treatment of Breast Cancer Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
    Yanqi Jiao et al, 2023, International Journal of Molecular Sciences CrossRef
  3. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals
    Shuwei Liang et al, 2017, Cancer Letters CrossRef
  4. Baicalein inhibits cell proliferation and induces apoptosis in brain glioma cells by downregulating the LGR4-EGFR pathway
    Xiaobing Zhang et al, 2024, Cancer Gene Therapy CrossRef
  5. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway
    YongHong Zhang et al, 2017, Archives of Biochemistry and Biophysics CrossRef
  6. Flavonoids: structure–function and mechanisms of action and opportunities for drug development
    Stephen Safe et al, 2021, Toxicological Research CrossRef
  7. Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells
    Yan Chen et al, 2017, Oncotarget CrossRef
  8. Baicalein blocked cervical carcinoma cell proliferation by targeting CCND1 via Wnt/β-catenin signaling pathway
    Xiulian Xia et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  9. Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30
    Yanlei Ji et al, 2016, Oncology Reports CrossRef
  10. Anticancer properties of baicalein: a review
    Ying Gao et al, 2016, Medicinal Chemistry Research CrossRef
  11. Potential of Estradiol‐Functionalized Polyisocyanide Hydrogels for Stimulating Tissue Regeneration of the Pelvic Floor
    Melissa J. J. van Velthoven et al, 2024, Advanced Therapeutics CrossRef
  12. High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma
    Li Yang et al, 2017, Oncotarget CrossRef
  13. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway
    Chunya Lu et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
  14. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways
    Hong-Chun Jiang et al, 2020, Human Cell CrossRef
  15. High concentration of estradiol has a negative correlation with free thyroxine during the second trimester of pregnancy
    Leqi He et al, 2022, Endocrine Connections CrossRef
  16. Controlling metastatic cancer: the role of phytochemicals in cell signaling
    Andrea Kapinova et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
  17. Baicalein Inhibits Metastatic Phenotypes in Nasopharyngeal Carcinoma Cells via a Focal Adhesion Protein Integrin β8
    Pichamon Kiatwuthinon et al, 2021, Pharmaceuticals CrossRef
  18. Mechanistic Role ofScutellaria baicalensisGeorgi in Breast Cancer Therapy
    Peng Yu et al, 2023, The American Journal of Chinese Medicine CrossRef
  19. Estrogenic flavonoids and their molecular mechanisms of action
    Ryoiti Kiyama, 2023, The Journal of Nutritional Biochemistry CrossRef
  20. Flavonoids as G Protein-coupled Receptors Ligands: New Potential Therapeutic Natural Drugs
    Alae Chda et al, 2023, Current Drug Targets CrossRef
  21. Baicalein—A review on its molecular mechanism against breast cancer and delivery strategies
    Shraddha Srivastava et al, 2023, Medicinal Chemistry Research CrossRef
  22. GPCRs as targets for flavonoids in cancer cells: new options for intervention
    Katrin Sak, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
  23. RETRACTED ARTICLE: Copper-based metal–organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade
    Sijie Wang et al, 2022, Journal of Nanobiotechnology CrossRef
  24. Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis
    WAN-JUN YAN et al, 2016, Molecular and Clinical Oncology CrossRef
  25. G protein-coupled receptors as promising cancer targets
    Ying Liu et al, 2016, Cancer Letters CrossRef
  26. Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors
    Wei-yi Gong et al, 2017, European Journal of Medicinal Chemistry CrossRef
  27. Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α
    Yan Chen et al, 2021, Clinical and Translational Medicine CrossRef
  28. Role of flavonoids in inhibiting triple-negative breast cancer
    Shuai Wang et al, 2024, Frontiers in Pharmacology CrossRef
  29. Dose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis
    Dongqing Zhu et al, 2016, PLOS ONE CrossRef
  30. Fermentation Extract of Naringenin Increases the Expression of Estrogenic Receptor β and Modulates Genes Related to the p53 Signalling Pathway, miR-200c and miR-141 in Human Colon Cancer Cells Exposed to BPA
    Sara Julietta Lozano-Herrera et al, 2022, Molecules CrossRef
  31. The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
    Riris Istighfari Jenie et al, 2018, Advanced Pharmaceutical Bulletin CrossRef
  32. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes
    Zhixiang Xu et al, 2018, Toxicology CrossRef
  33. The most recent progress of baicalein in its anti-neoplastic effects and mechanisms
    Chenjing Lei et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  34. Protective Effect of Baicalein on oxLDL-induced Oxidative Stress and Inflammation Injury in Endothelial Cell
    Changjiang Du et al, 2017, International Journal of Pharmacology CrossRef
  35. Hormone therapy and breast cancer: emerging steroid receptor mechanisms
    Meghan S Perkins et al, 2018, Journal of Molecular Endocrinology CrossRef
  36. Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor‐positive breast cancer therapy: An in vitro study
    Zhixiang Xu et al, 2020, Environmental Toxicology CrossRef
  37. Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
    Elika Verma et al, 2021, Journal of Functional Foods CrossRef
  38. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis
    Damian Jacenik et al, 2019, World Journal of Gastroenterology CrossRef
  39. Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells
    Joanna Bernasinska-Slomczewska et al, 2024, Molecules CrossRef
  40. The potential role of dietary plant ingredients against mammary cancer: a comprehensive review
    Amjad Hussain et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  41. Baicalein suppresses HER2‐mediated malignant transformation of HER2‐overexpressing ovarian cancer cells by downregulating HER2 gene expression
    Tzu‐Chao Chuang et al, 2023, Environmental Toxicology CrossRef
  42. Imbalance between proliferation and apoptosis−related impaired GPR30 expression is involved in preeclampsia
    Jianxin Li et al, 2016, Cell and Tissue Research CrossRef
  43. Beyond the Antioxidant Activity of Dietary Polyphenols in Cancer: the Modulation of Estrogen Receptors (ERs) Signaling
    Manuela Cipolletti et al, 2018, International Journal of Molecular Sciences CrossRef
  44. 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy
    Zhixiang Xu et al, 2019, Environmental Pollution CrossRef
  45. Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction
    Defeng Xu et al, 2017, Oncotarget CrossRef
  46. MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells
    Jun Lin et al, 2017, Experimental and Therapeutic Medicine CrossRef
  47. The Role of GPER Signaling in Carcinogenesis: A Focus on Prostate Cancer
    Marília I. Figueira et al, 2018, Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs CrossRef
  48. Baicalein disturbs the morphological plasticity and motility of breast adenocarcinoma cells depending on the tumor microenvironment
    Takeshi Terabayashi et al, 2018, Genes to Cells CrossRef
  49. Baicalein induces cervical cancer apoptosis through the NF-κB signaling pathway
    Xiaolan Yu et al, 2018, Molecular Medicine Reports CrossRef
  50. miR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression
    Fang Ma et al, 2017, Experimental and Therapeutic Medicine CrossRef
  51. Traditional uses, ten-years research progress on phytochemistry and pharmacology, and clinical studies of the genus Scutellaria
    Jie Shen et al, 2021, Journal of Ethnopharmacology CrossRef
  52. Baicalein inhibits FURIN‐MT1‐MMP‐mediated invasion of ectopic endometrial stromal cells in endometriosis possibly by reducing the secretion of TGFB1
    Jun‐Ya Ke et al, 2021, American Journal of Reproductive Immunology CrossRef
  53. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling
    Yan Chen et al, 2019, Biochemical Pharmacology CrossRef
  54. Baicalein inhibits cell development, metastasis and EMT and induces apoptosis by regulating ERK signaling pathway in osteosarcoma
    Hang Lin et al, 2020, Journal of Receptors and Signal Transduction CrossRef
  55. G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications
    Jeffrey B. Arterburn et al, 2023, Annual Review of Pharmacology and Toxicology CrossRef